Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cost-effectiveness
80%
Primary Care
77%
Randomized Controlled Trial
65%
Economic Evaluation
40%
Usual Care
35%
Chronic Obstructive Pulmonary Disease
33%
Quality-adjusted Life Years
31%
Cluster Randomized Trial
22%
Self-management
21%
Cost-effectiveness Analysis
20%
Clinical Efficacy
20%
Atrial Fibrillation
18%
Physiotherapist
16%
General Practitioners
15%
Self-monitoring
14%
Physiotherapy
13%
Cost-utility Analysis
13%
Osteoarthritis
13%
Well Groups
12%
Lee Silverman Voice Treatment
12%
Language Therapy
12%
Speech Therapy
12%
Decision-analytic Model
11%
Telemonitoring
11%
Hypertension Management
11%
Blood Pressure
11%
Musculoskeletal Pain
11%
Corticosteroid Injection
11%
General Practice
10%
Trial Registration
10%
Pilot Randomized Controlled Trial
10%
Review Evaluation
10%
Parkinson's Disease
10%
Transient Ischemic Attack
10%
Life-years Gained
10%
Quality of Life
10%
Anticoagulation
9%
Physical Activity
9%
Intervention Group
9%
China
9%
Back Pain
9%
Randomized Trial
8%
Home-based
8%
National Health Service
8%
Incremental Cost-effectiveness Ratio
8%
Process Evaluation
8%
Primary Care Patients
8%
Reach-to-grasp
8%
Noninvasive Ventilation
8%
Sciatica
8%
Medicine and Dentistry
Randomized Controlled Trial
100%
Cost-Effectiveness Analysis
75%
Primary Health Care
73%
Health Care Cost
59%
Chronic Obstructive Pulmonary Disease
47%
Arm
32%
Apoplexy
25%
Systematic Review
24%
Quality Adjusted Life Year
21%
Blood Pressure
17%
Quality of Life
16%
Physiotherapy
16%
Anticoagulation
14%
Outpatient
13%
Self Monitoring
13%
Atrial Fibrillation
12%
Speech and Language Rehabilitation
12%
Lung
11%
Case Finding
10%
Adverse Event
10%
Physiotherapist
10%
Patient Referral
10%
Parkinson's Disease
10%
Antihypertensive Agent
9%
Remote Patient Monitoring
9%
Musculoskeletal Pain
8%
Systolic Blood Pressure
8%
Transient Ischemic Attack
8%
General Practitioner
8%
Clinician
8%
Noninvasive Ventilation
8%
Knee Osteoarthritis
8%
National Health Service
7%
Anticoagulant Therapy
7%
Physical Activity
7%
General Medicine
7%
Randomized Clinical Trial
7%
Cardiovascular Disease
7%
Low Back Pain
6%
Cohort Analysis
6%
Low and Middle Income Countries
6%
Polyp
6%
Mass Screening
6%
Carpal Tunnel Syndrome
6%
Uterus Bleeding
6%
Liver Cirrhosis
6%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
6%
Titrimetry
5%
Sciatica
5%
Nicotine Withdrawal
5%
Nursing and Health Professions
Cost Effectiveness Analysis
88%
Primary Medical Care
72%
Obstructive Lung Disease
33%
Quality Adjusted Life Year
29%
Economic Evaluation
29%
Self Care
29%
Systematic Review
27%
Physiotherapy
24%
Cerebrovascular Accident
23%
Blood Pressure
22%
Quality of Life
17%
Self Monitoring
15%
Atrial Fibrillation
14%
Physiotherapist
13%
Osteoarthritis
13%
Cost Utility Analysis
13%
Patient Referral
12%
Speech and Language Rehabilitation
12%
Knee Osteoarthritis
12%
General Practitioner
11%
Telemonitoring
11%
Practice Guideline
10%
Anticoagulation
10%
Randomization
10%
Parkinson's Disease
10%
Mass Screening
10%
Health Care
10%
Musculoskeletal Pain
9%
Antihypertensive Agent
9%
Cardiovascular Disease
9%
General Practice
8%
Socialized Medicine
8%
Anticoagulant Therapy
8%
Outpatient
8%
Noninvasive Ventilation
8%
Adverse Event
7%
Confidence Interval
7%
Economic Analysis
7%
Titrimetry
7%
Base
7%
Primary Health Care
7%
Diseases
6%
Nicotine Withdrawal
6%
Systolic Blood Pressure
6%
Incremental Cost-Effectiveness Ratio
6%
Transient Ischemic Attack
6%
Splint
6%
Carpal Tunnel Syndrome
6%
Shoulder Pain
6%
Warfarin
5%
